(Q42236658)

English

BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens.

scientific article published on 14 December 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

BacMam virus-based surface display of the infectious bronchitis virus (IBV) S1 glycoprotein confers strong protection against virulent IBV challenge in chickens. (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

based on heuristic

inferred from title

infectious bronchitis virus

object named as

infectious bronchitis virus

1 reference

based on heuristic

inferred from title

author name string

Jie Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Xiao-Wei Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Tie-Zhu Tong

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Yu Ye

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Ming Liao

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Hui-Ying Fan

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

14 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

664-670

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Coronavirus avian infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Avian infectious bronchitis and deep pectoral myopathy - a case control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Attenuated live vaccine usage affects accurate measures of virus diversity and mutation rates in avian coronavirus infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Cytotoxic T lymphocytes are critical in the control of infectious bronchitis virus in poultry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Completion of the sequence of the genome of the coronavirus avian infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Recombinant avian infectious bronchitis virus expressing a heterologous spike gene demonstrates that the spike protein is a determinant of cell tropism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

The S1 glycoprotein but not the N or M proteins of avian infectious bronchitis virus induces protection in vaccinated chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Protection of chickens from infectious bronchitis by in ovo and intramuscular vaccination with a DNA vaccine expressing the S1 glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Construction and immunogenicity of a recombinant fowlpox vaccine coexpressing S1 glycoprotein of infectious bronchitis virus and chicken IL-18.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Avian metapneumoviruses expressing Infectious Bronchitis virus genes are stable and induce protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Transduction of avian cells with recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus-mediated gene expression in chicken primary cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Transient and stable expression of the HCV envelope glycoproteins in cell lines and primary hepatocytes transduced with a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus-based vaccination vectors allow for efficient induction of immune responses against plasmodium falciparum circumsporozoite protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus diversity and molecular biology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

BacMam immunization partially protects pigs against sublethal challenge with African swine fever virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus vectors elicit antigen-specific immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Structures of Two Coronavirus Main Proteases: Implications for Substrate Binding and Antiviral Drug Design

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

A baculovirus dual expression system-based vaccine confers complete protection against lethal challenge with H9N2 avian influenza virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Rat Cytomegalovirus: Studies on the Viral Genome and the Proteins of Virions and Nucleocapsids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Opportunities and challenges for the baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Breadth of protection of the respiratory tract provided by different live-attenuated infectious bronchitis vaccines against challenge with infectious bronchitis viruses of heterologous serotypes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Cross-protective immune responses elicited by a Korean variant of infectious bronchitis virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

A novel B-cell epitope of avian infectious bronchitis virus N protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

The immunoreactivity of a chimeric multi-epitope DNA vaccine against IBV in chickens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Baculovirus-mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

How to avoid complement attack in baculovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Screening of complement inhibitors: shielded baculoviruses increase the safety and efficacy of gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

A GP64-null baculovirus pseudotyped with vesicular stomatitis virus G protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Adaptive immune responses elicited by baculovirus and impacts on subsequent transgene expression in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.12.006

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.12.006

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42236658&oldid=2154440314"